Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824509 · ClinicalTrials.gov registry record
Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation
A clinical trial, sponsored by MaineHealth.
- Completed
- Registry status
- 140
- Enrollment target
NCT03824509: Completed study, sponsored by MaineHealth.
NCT03824509 is a clinical trial that has completed, run by MaineHealth. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03824509 has completed, sponsored by MaineHealth.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
The goal is to review patients with known atrial fibrillation who suffered a stroke or transient ischemic attack (TIA) to incorporate any structural heart abnormalities into the overall clinical picture. A better understanding of the additional risk of a stroke or TIA in patients with specific structural abnormalities may be beneficial in guiding future treatment decisions.
Primary Outcome
1)Assess left atrial volume using volumetric measurements and left ventricular septal and posterior wall thickness from 2-D transthoracic echocardiography studies in patients with known atrial fibrillation who suffered a stroke or TIA. We would then compare these data to control patients with atrial fibrillation with matched CHA2DS2-VASc scores, age (+/- 5 years), and gender who have no history of stroke or TIA.
Interventions
- OTHER Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-05-21 |
What the finished NCT03824509 record still lists
NCT03824509 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Chart Review is the first listed.
NCT03824509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03824509 about?
NCT03824509 is a clinical study titled "Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation". The goal is to review patients with known atrial fibrillation who suffered a stroke or transient ischemic attack (TIA) to incorporate any structural heart abnormalities into the overall clinical picture. A better understanding of the additional risk of a stroke or TIA in patients with specific struc...
What is the current status of trial NCT03824509?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2019-01-01. Estimated completion is 2020-05-21.
What interventions are being tested in trial NCT03824509?
The interventions under investigation include: Chart Review (OTHER).
Who is sponsoring clinical trial NCT03824509?
This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI